Study identifier:N3566000000
ClinicalTrials.gov identifier:NCT04901260
EudraCT identifier:N/A
CTIS identifier:N/A
AMAZE™ Asthma Implementation Quality Improvement Study
asthma
N/A
No
-
All
117
Observational
18 Years +
Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jul 2022 by AstraZeneca
AstraZeneca
Greater Austin Allergy, Evidera, Inc.
No locations available
Arms | Assigned Interventions |
---|---|
Quality Initiative Each participant will be asked to complete the symptoms log daily for up to 6 months. Additional surveys will be completed throughout the study by participants and GAA clinical staff. | - |